TILE Stock Recent News

Interface (TILE) could produce exceptional returns because of its solid growth attributes.

Interface, Inc. (NASDAQ:TILE ) Q1 2025 Earnings Conference Call May 2, 2025 8:00 AM ET Company Participants Christine Needles – Global Communications Laurel Hurd – Chief Executive Officer Bruce Hausmann – Chief Financial Officer Conference Call Participants Brian Biros – Thompson Research Group Alex Paris – Barrington Research David MacGregor – Longbow Research Operator Thank you for standing by, and welcome to the Interface, Inc. First Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Interface (TILE) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.24 per share a year ago.

ATLANTA--(BUSINESS WIRE)--Interface, Inc. (Nasdaq: TILE), a worldwide commercial flooring company and global leader in sustainability, today announced results for the first quarter ended March 30, 2025. First quarter highlights: Net sales totaled $297 million, up 2.6% year-over-year and up 4.1% currency-neutral. GAAP earnings per diluted share of $0.22; Adjusted earnings per diluted share of $0.25. Momentum continues with One Interface strategy. “We delivered a solid start to the year, with cur.

ATLANTA--(BUSINESS WIRE)--FLOR expanded its carbon negative area rug collection.

ATLANTA--(BUSINESS WIRE)--Interface will release its first quarter 2025 results on Friday, May 2, 2025, prior to the open of the market.

ATLANTA--(BUSINESS WIRE)--Interface announced it is incorporating captured carbon in its manufacturing processes as a key raw material to meet its bold climate commitments.

Interface, Inc. is poised for growth, with earnings projected to grow at least twice as fast as revenue over the next three years. Despite recent slower growth and the possibility of a fundamentals pullback, Interface gets a Buy rating with a one-year price target of $21.25. Competitive advantages include innovative design, global manufacturing capabilities, and optimization initiatives like automation and a globalized supply chain team.

--Revelation Neuro, Inc. is focused on advancing development of a Non-Implantable Artificial Intelligence (“AI”) Powered BCI Technology-- --Helius' existing IP portfolio and extensive data warehouse provides a solid foundation for AI algorithm development-- --Helius to Present at the 37 th Annual ROTH Conference on Monday, March 17 at 12:00pm PT-- NEWTOWN, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for improving balance and gait deficits and reducing the risk of falling, today announced the establishment of Revelation Neuro, Inc. (“Revelation Neuro”), its wholly-owned private subsidiary focused on the development of non-implantable AI powered BCI technology.

Qualcomm CEO Cristiano Amon said Tuesday (March 11) that artificial intelligence (AI) is ushering in the next fundamental shift in how humans interact with technology, describing it as a “generation change” poised to reshape the tech landscape and redefine user experiences across devices.